tiprankstipranks
Trending News
More News >
Genmab A/S (GMAB)
NASDAQ:GMAB
Advertisement

Genmab (GMAB) Similar Stocks

Compare
698 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Genmab
$33.56
$20.30B
16.62
42.87%
5 Buy
1 Hold
1 Sell
Moderate Buy
BioMarin Pharmaceutical
$55.43
$10.64B
16.42
-19.62%
18 Buy
4 Hold
0 Sell
Strong Buy
Incyte
$86.85
$16.96B
19.74
28.69%
8 Buy
9 Hold
1 Sell
Moderate Buy
Ascendis Pharma
$204.05
$12.36B
46.65%
16 Buy
0 Hold
0 Sell
Strong Buy
BioNTech SE
$105.49
$25.36B
-14.01%
12 Buy
4 Hold
0 Sell
Strong Buy
Royalty Pharma
$36.07
$21.04B
15.70
33.59%
5 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GMAB
Genmab
33.56
10.13
43.24%
BMRN
BioMarin Pharmaceutical
55.43
-13.53
-19.62%
INCY
Incyte
86.85
21.09
32.07%
ASND
Ascendis Pharma
204.05
64.91
46.65%
BNTX
BioNTech SE
105.49
-16.06
-13.21%
RPRX
Royalty Pharma
36.07
9.25
34.49%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis